Moving Myeloid Leukemia Drug Discovery Into the Third Dimension

Frontiers in Pediatrics - Switzerland
doi 10.3389/fped.2019.00314
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Frontiers Media SA

Related search

Drug Repurposing for the Treatment of Acute Myeloid Leukemia

Frontiers in Medicine
Medicine
2017English

Acute Myeloid Leukemia Drug Development in the Post‐Venetoclax Era

American Journal of Hematology
Hematology
2019English

Chronic Eosinophilic Leukemia Transformation Into Acute Myeloid Leukemia With Monocytic Differentiation

Case Reports in Internal Medicine
2014English

Systemic Mastocytosis With Chronic Myelomonocytic Leukemia Followed by Transformation Into Acute Myeloid Leukemia

Acta Haematologica Polonica
OncologyHematology
2020English

Therapeutic Drug Monitoring of Imatinib for Chronic Myeloid Leukemia Patients

2012English

A New Dimension in Drug Discovery: Reversing Epithelial–mesenchymal Transition (EMT)

Cell Death and Disease
Molecular NeuroscienceImmunologyCell BiologyCancer ResearchCellularMedicine
2016English

New Insights Into Antigen Specific Immunotherapy for Chronic Myeloid Leukemia

Cancer Cell International
Cancer ResearchOncologyGenetics
2012English

The Third Dimension in Chemistry

Journal of Chemical Education
ChemistryEducation
1956English

New Insight Into Acute Myeloid Leukemia Classification and Risk Stratification

Cancer therapy & Oncology International Journal
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy